Analytical Data
-
基因名
Igk
- Application
-
别名
IGKC; HCAK1; Km; Immunoglobulin Kappa Constant; IgA Kappa
-
种属
Mouse
-
表达系统
HEK293
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P01837
-
表达区间
Arg1~Cys107
-
分子量
14kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Igk (Immunoglobulin kappa) recombinant proteins play a critical role in immunology and biotechnology due to their involvement in the immune response. The kappa light chain is one of the two types of light chains found in antibodies, which are essential for the adaptive immune system's ability to recognize and neutralize pathogens. The study of Igk recombinant proteins is vital for understanding antibody diversity, as they are produced through somatic recombination and gene rearrangement processes in B cells. Researchers utilize recombinant technology to express Igk proteins in various systems, enabling detailed analysis of their structure and function. This has significant implications for the development of therapeutic antibodies, vaccines, and diagnostic tools. Additionally, the production of Igk recombinant proteins allows for studies on antibody-antigen interactions and the design of engineered antibodies with enhanced specificity and affinity. With advancements in genetic engineering and protein expression systems, the manipulation and study of Igk recombinant proteins are paving the way for innovations in therapeutic strategies and our understanding of immune mechanisms. This research not only enhances our knowledge of antibody biology but also holds promise for breakthroughs in treating diseases, including cancers, autoimmune disorders, and infectious diseases. Overall, the exploration of Igk recombinant proteins is a dynamic field that intersects immunology and biotechnology, fostering advancements in both basic and applied sciences.
